| Alan W Thomas, MD | |
|
500 W Broadway St, Missoula, MT 59802-4008 | |
| (406) 728-2539 | |
| (406) 728-2709 |
| Full Name | Alan W Thomas |
|---|---|
| Gender | Male |
| Speciality | Medical Oncology |
| Experience | 35 Years |
| Location | 500 W Broadway St, Missoula, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548297468 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 8522 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St. Patrick Hospital | Missoula, MT | Hospital |
| Providence St Joseph Medical Center | Polson, MT | Hospital |
| Marcus Daly Memorial Hospital - Cah | Hamilton, MT | Hospital |
| Providence Portland Medical Center | Portland, OR | Hospital |
| Clark Fork Valley Hospital | Plains, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health And Services Mt | 6608786306 | 272 |
News Archive
Political and private sector leaders met on Thursday at a High-Level Meeting on Scaling Up Nutrition, held in New York on the sidelines of the 67th U.N. General Assembly session, the U.N. News Centre reports.
A novel strategy has been developed by Novateur Ventures, which provides new hope in battle against COVID-19. The study titled 'A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes' was published in Frontiers in Pharmacology, a leading peer-reviewed journal.
Bayer HealthCare today announced that the company has begun to enroll patients in the COAST trial studying Stivarga® (regorafenib) tablets in colorectal cancer (CRC) patients with resected liver metastases.
Authentidate Holding Corp., a worldwide provider of secure health information exchange, workflow management services and telehealth solutions, today announced that it received a deficiency notification from the Nasdaq Stock Market dated May 26, 2010 as the result of Authentidate not complying with the $1 minimum closing bid price requirement of Nasdaq Listing Rule 5550(a)(2) during the consecutive 30 business day period from April 13, 2010 through May 25, 2010. This notification has no effect on the listing of the company's common stock at this time.
As part of the search for better ways to track and clean up soil contaminants, scientists at the U.S. Department of Energy's Brookhaven National Laboratory and Stony Brook University have developed a new way to "image" the internal chemistry of bacteria.
› Verified 5 days ago
| Entity Name | Providence Health & Services Mt |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144319138 PECOS PAC ID: 6608786306 Enrollment ID: O20031229000787 |
News Archive
Political and private sector leaders met on Thursday at a High-Level Meeting on Scaling Up Nutrition, held in New York on the sidelines of the 67th U.N. General Assembly session, the U.N. News Centre reports.
A novel strategy has been developed by Novateur Ventures, which provides new hope in battle against COVID-19. The study titled 'A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes' was published in Frontiers in Pharmacology, a leading peer-reviewed journal.
Bayer HealthCare today announced that the company has begun to enroll patients in the COAST trial studying Stivarga® (regorafenib) tablets in colorectal cancer (CRC) patients with resected liver metastases.
Authentidate Holding Corp., a worldwide provider of secure health information exchange, workflow management services and telehealth solutions, today announced that it received a deficiency notification from the Nasdaq Stock Market dated May 26, 2010 as the result of Authentidate not complying with the $1 minimum closing bid price requirement of Nasdaq Listing Rule 5550(a)(2) during the consecutive 30 business day period from April 13, 2010 through May 25, 2010. This notification has no effect on the listing of the company's common stock at this time.
As part of the search for better ways to track and clean up soil contaminants, scientists at the U.S. Department of Energy's Brookhaven National Laboratory and Stony Brook University have developed a new way to "image" the internal chemistry of bacteria.
› Verified 5 days ago
| Entity Name | Providence St Joseph Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669655528 PECOS PAC ID: 0446230247 Enrollment ID: O20040910001134 |
News Archive
Political and private sector leaders met on Thursday at a High-Level Meeting on Scaling Up Nutrition, held in New York on the sidelines of the 67th U.N. General Assembly session, the U.N. News Centre reports.
A novel strategy has been developed by Novateur Ventures, which provides new hope in battle against COVID-19. The study titled 'A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes' was published in Frontiers in Pharmacology, a leading peer-reviewed journal.
Bayer HealthCare today announced that the company has begun to enroll patients in the COAST trial studying Stivarga® (regorafenib) tablets in colorectal cancer (CRC) patients with resected liver metastases.
Authentidate Holding Corp., a worldwide provider of secure health information exchange, workflow management services and telehealth solutions, today announced that it received a deficiency notification from the Nasdaq Stock Market dated May 26, 2010 as the result of Authentidate not complying with the $1 minimum closing bid price requirement of Nasdaq Listing Rule 5550(a)(2) during the consecutive 30 business day period from April 13, 2010 through May 25, 2010. This notification has no effect on the listing of the company's common stock at this time.
As part of the search for better ways to track and clean up soil contaminants, scientists at the U.S. Department of Energy's Brookhaven National Laboratory and Stony Brook University have developed a new way to "image" the internal chemistry of bacteria.
› Verified 5 days ago
| Entity Name | Rchp Billings - Missoula Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376946913 PECOS PAC ID: 8426370842 Enrollment ID: O20150312000492 |
News Archive
Political and private sector leaders met on Thursday at a High-Level Meeting on Scaling Up Nutrition, held in New York on the sidelines of the 67th U.N. General Assembly session, the U.N. News Centre reports.
A novel strategy has been developed by Novateur Ventures, which provides new hope in battle against COVID-19. The study titled 'A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes' was published in Frontiers in Pharmacology, a leading peer-reviewed journal.
Bayer HealthCare today announced that the company has begun to enroll patients in the COAST trial studying Stivarga® (regorafenib) tablets in colorectal cancer (CRC) patients with resected liver metastases.
Authentidate Holding Corp., a worldwide provider of secure health information exchange, workflow management services and telehealth solutions, today announced that it received a deficiency notification from the Nasdaq Stock Market dated May 26, 2010 as the result of Authentidate not complying with the $1 minimum closing bid price requirement of Nasdaq Listing Rule 5550(a)(2) during the consecutive 30 business day period from April 13, 2010 through May 25, 2010. This notification has no effect on the listing of the company's common stock at this time.
As part of the search for better ways to track and clean up soil contaminants, scientists at the U.S. Department of Energy's Brookhaven National Laboratory and Stony Brook University have developed a new way to "image" the internal chemistry of bacteria.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alan W Thomas, MD Po Box 12, Liberty Lake, WA 99019-0012 Ph: (406) 327-1918 | Alan W Thomas, MD 500 W Broadway St, Missoula, MT 59802-4008 Ph: (406) 728-2539 |
News Archive
Political and private sector leaders met on Thursday at a High-Level Meeting on Scaling Up Nutrition, held in New York on the sidelines of the 67th U.N. General Assembly session, the U.N. News Centre reports.
A novel strategy has been developed by Novateur Ventures, which provides new hope in battle against COVID-19. The study titled 'A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes' was published in Frontiers in Pharmacology, a leading peer-reviewed journal.
Bayer HealthCare today announced that the company has begun to enroll patients in the COAST trial studying Stivarga® (regorafenib) tablets in colorectal cancer (CRC) patients with resected liver metastases.
Authentidate Holding Corp., a worldwide provider of secure health information exchange, workflow management services and telehealth solutions, today announced that it received a deficiency notification from the Nasdaq Stock Market dated May 26, 2010 as the result of Authentidate not complying with the $1 minimum closing bid price requirement of Nasdaq Listing Rule 5550(a)(2) during the consecutive 30 business day period from April 13, 2010 through May 25, 2010. This notification has no effect on the listing of the company's common stock at this time.
As part of the search for better ways to track and clean up soil contaminants, scientists at the U.S. Department of Energy's Brookhaven National Laboratory and Stony Brook University have developed a new way to "image" the internal chemistry of bacteria.
› Verified 5 days ago
Mr. George Bandow, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 2809 Great Northern Loop, Suite 200, Missoula, MT 59808 Phone: 406-541-7139 Fax: 406-541-7143 | |
Simone Musco, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 500 W Broadway St, Ste 320, Missoula, MT 59802 Phone: 406-329-5615 | |
Rolf H O Holle, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1782 Elison Ln Unit 3, Missoula, MT 59802 Phone: 406-544-1871 | |
John David Anthony Lakatua, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 500 West Broadway, Missoula, MT 59802 Phone: 406-721-5600 Fax: 406-721-3907 | |
Mr. Curtis G Wickre, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 500 W Broadway St, 4th Floor, Missoula, MT 59802 Phone: 406-327-1900 | |
Dr. Charlotte Nelson, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 500 W Broadway St, Missoula, MT 59802 Phone: 406-327-1613 | |
Michele A Danicich, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 900 N Orange St Ste 304, Missoula, MT 59802 Phone: 406-329-5781 Fax: 406-327-3331 |